Adaptive Biotechnologies Corp (NAS:ADPT)
$ 3.61 -0.29 (-7.44%) Market Cap: 532.00 Mil Enterprise Value: 319.62 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 72/100

Adaptive Biotechnologies Corp at William Blair Growth Stock Conference Transcript

Jun 09, 2020 / 05:00PM GMT
Release Date Price: $41.5 (+5.28%)
Brian David Weinstein
William Blair & Company L.L.C., Research Division - Partner & Healthcare Analyst

Good afternoon or good morning depending on where you are. And welcome to the virtual fireside chat with Adaptive Biotechnologies co-Founder and CEO, and a fellow northern suburbs of Chicago guy, Chad Robins, though his high school wasn't just cool as mine. We'll debate that. My name is Brian Weinstein, and I'm the analyst here at William Blair covering Adaptive and certain areas within diagnostics, life science, tools and medical technology for our firm. Joining me is my associate, the team's COO, if you will, Andrew Brackmann.

A reminder, the team Weinstein is hosting some events along with the conference.

So we did a Peloton ride this morning, admittedly not my best performance, but will be much, much better tomorrow when we do another group ride at 7:00 a.m. Central. We have one on Thursday at 4:00 p.m. Central, and I believe Chad Robins will be joining for 1 or 2 of these. For instructions on how to access that, take a look at last weekend's backstreet's note or e-mail us

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot